1. Home
  2. ESRT vs NVCT Comparison

ESRT vs NVCT Comparison

Compare ESRT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Empire State Realty Trust Inc.

ESRT

Empire State Realty Trust Inc.

SELL

Current Price

$5.42

Market Cap

826.6M

Sector

Real Estate

ML Signal

SELL

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

SELL

Current Price

$19.03

Market Cap

672.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ESRT
NVCT
Founded
2011
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.6M
672.1M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
ESRT
NVCT
Price
$5.42
$19.03
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$5.50
★ $35.40
AVG Volume (30 Days)
★ 3.4M
186.8K
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 2.56%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $768,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.05
N/A
52 Week Low
$3.93
$5.77
52 Week High
$7.13
$29.28

Technical Indicators

Market Signals
Indicator
ESRT
NVCT
Relative Strength Index (RSI) 69.58 44.66
Support Level $5.25 $17.73
Resistance Level $5.85 $22.49
Average True Range (ATR) 0.15 1.45
MACD 0.01 0.14
Stochastic Oscillator 82.91 36.82

Price Performance

Historical Comparison
ESRT
NVCT

About ESRT Empire State Realty Trust Inc.

Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: